NRx agrees to relinquish rights to experimental Covid-19 therapy in settlement with Relief Therapeutics

Radnor-based NRx Pharmaceuticals is transferring to Relief Therapeutics all the assets it previously used in the development of Zyesami.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news